If a patient with SLE finds that she is pregnant and cannot continue the pregnancy because of her disease problems or the development of her child or family and social problems, is termination of pregnancy the same as in other people? This question needs to be divided into two cases: one is patients with stable disease, no major visceral involvement, and whose drug use has been reduced to maintenance doses. The other is patients with initial or recurrent disease and on full dose therapy. In the first case, the drugs currently used for abortion (mifepristone + misoprostol) and Levanox (a mid-term abortion induction drug) are relatively safe, including abortion, and the patient can maintain the original treatment during the procedure. In the second case, it is more complicated because SLE is a disease involving multiple systems, so different patients may have different manifestations when the disease progresses, such as nephritis in some cases, severe pulmonary hypertension in others with heart involvement, and severe thrombocytopenia in others. In such cases, termination of pregnancy may have to give way to treatment of the primary disease, and it is more appropriate to wait until the primary disease is relatively stable before choosing to induce labor. Such cases often require consultation between immunologists and obstetricians and gynecologists to find an appropriate entry point for termination of pregnancy.